PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
14.02%
Revenue growth under 50% of FSLR's 92.14%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
19.50%
Gross profit growth under 50% of FSLR's 168.42%. Michael Burry would be concerned about a severe competitive disadvantage.
47.10%
EBIT growth below 50% of FSLR's 422.24%. Michael Burry would suspect deeper competitive or cost structure issues.
47.10%
Operating income growth under 50% of FSLR's 422.24%. Michael Burry would be concerned about deeper cost or sales issues.
18.20%
Net income growth under 50% of FSLR's 693.21%. Michael Burry would suspect the firm is falling well behind a key competitor.
14.29%
EPS growth under 50% of FSLR's 680.91%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
23.08%
Diluted EPS growth under 50% of FSLR's 698.29%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-4.47%
Share reduction while FSLR is at 0.31%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-6.70%
Reduced diluted shares while FSLR is at 0.52%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-740.28%
Negative OCF growth while FSLR is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-250.83%
Negative FCF growth while FSLR is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
1309.36%
10Y revenue/share CAGR 1.25-1.5x FSLR's 1096.00%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
1309.36%
5Y revenue/share CAGR 1.25-1.5x FSLR's 1096.00%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
1309.36%
3Y revenue/share CAGR 1.25-1.5x FSLR's 1096.00%. Bruce Berkowitz might see better product or regional expansions than the competitor.
-2660.50%
Negative 10Y OCF/share CAGR while FSLR stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-2660.50%
Negative 5Y OCF/share CAGR while FSLR is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-2660.50%
Negative 3Y OCF/share CAGR while FSLR stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
220.80%
Net income/share CAGR at 75-90% of FSLR's 247.06%. Bill Ackman would press for strategic moves to boost long-term earnings.
220.80%
5Y net income/share CAGR at 75-90% of FSLR's 247.06%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
220.80%
3Y net income/share CAGR 75-90% of FSLR's 247.06%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-9.44%
Firm’s AR is declining while FSLR shows 28.57%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-12.62%
Inventory is declining while FSLR stands at 56.85%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
2.21%
Asset growth well under 50% of FSLR's 126.74%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
7.35%
Under 50% of FSLR's 238.27%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
1.10%
R&D dropping or stable vs. FSLR's 4.96%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-1.63%
We cut SG&A while FSLR invests at 48.52%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.